Literature DB >> 22405629

Prediction of haematoma expansion with the CTA spot sign: a useful biomarker?

Joanna M Wardlaw1.   

Abstract

Mesh：

Year:  2012        PMID： 22405629     DOI： 10.1016/S1474-4422(12)70045-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

1.  CT perfusion spot sign improves sensitivity for prediction of outcome compared with CTA and postcontrast CT.

Authors:  A Koculym; T J Huynh; R Jakubovic; L Zhang; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

2.  CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage.

Authors:  H Bart Brouwers; Guido J Falcone; Kristen A McNamara; Alison M Ayres; Alexandra Oleinik; Kristin Schwab; Javier M Romero; Anand Viswanathan; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

3.  Advances in stroke: Imaging 2013.

Authors:  Wolf-Dieter Heiss; Chelsea S Kidwell
Journal:  Stroke       Date:  2014-01-16       Impact factor: 7.914

Review 4.  Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review.

Authors:  H Bart Brouwers; Joshua N Goldstein; Javier M Romero; Jonathan Rosand
Journal:  Stroke       Date:  2012-11-06       Impact factor: 7.914

Review 5.  Treatment of intracerebral haemorrhage with tranexamic acid - A review of current evidence and ongoing trials.

Authors:  Zhe Kang Law; Atte Meretoja; Stefan T Engelter; Hanne Christensen; Eugenia-Maria Muresan; Solveig B Glad; Liping Liu; Philip M Bath; Nikola Sprigg
Journal:  Eur Stroke J       Date:  2016-10-26

Review 6.  The accuracy of spot sign in predicting hematoma expansion after intracerebral hemorrhage: a systematic review and meta-analysis.

Authors:  Fei-Zhou Du; Rui Jiang; Ming Gu; Ci He; Jing Guan
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.